肌醇

该研究显示肌醇衍生物Ino-C2-PAF下调炎症相关基因，可能具有抗炎作用，未证实肌醇具有致敏风险。

The study shows that inositol derivative Ino-C2-PAF downregulates inflammatory genes, suggesting anti-inflammatory effects; no sensitization risk for inositol is demonstrated.

该综述指出肌醇在某些小鼠模型中可预防神经管缺陷，表明肌醇具有保护作用，而非风险。

The review indicates inositol prevents NTD in some mouse models, suggesting a protective role, not a risk.

该综述指出肌醇补充可预防糖尿病胚胎病，表明肌醇具有保护作用，而非风险。

The review indicates inositol supplementation prevents diabetic embryopathy, suggesting a protective role, not a risk.

该研究显示肌醇可预防高糖诱导的神经管缺陷，表明肌醇具有保护作用，而非风险。

The study shows inositol prevents glucose-induced neural tube defects, indicating a protective role, not a risk.

该研究显示肌醇可预防锂诱导的致畸作用，表明肌醇本身无致畸风险，反而具有保护作用。

The study shows that inositol prevents lithium-induced teratogenesis, indicating inositol itself is not teratogenic but protective.

该文献为综述，提出锂的致畸作用可能通过抑制肌醇磷酸酶导致肌醇耗竭的假说，但未直接研究肌醇本身的风险。

This review proposes a hypothesis that lithium teratogenicity may be mediated by inositol depletion, but does not directly study inositol risk.

该文献研究的是scyllo-肌醇-G6（scyllo-G6）作为分子转运体增强vitagen的经皮渗透，肌醇衍生物作为渗透促进剂，未单独评估肌醇的经皮渗透风险；结果显示scyllo-G6细胞毒性可忽略不计，且未提及任何皮肤刺激或致敏风险，因此肌醇在此研究中未表现出经皮渗透风险。

This study investigates scyllo-inositol-G6 (scyllo-G6) as a molecular transporter to enhance transdermal delivery of vitagen, not inositol alone. Results show negligible cytotoxicity and no mention of skin irritation or sensitization, indicating no risk for inositol in this context.

该文献研究的是复合物Putocrin®（含2%异山梨醇二甲醚、1%戊二醇、0.5%肌醇）的安全性和促渗功效，未单独研究肌醇的经皮渗透风险；结果显示2.5% Putocrin®对细胞活力、皮肤形态无显著影响，且无毒性，因此肌醇作为成分之一未表现出经皮渗透风险。

This study evaluates the safety and efficacy of the combination Putocrin® (containing 2% isosorbide dimethyl ether, 1% pentanediol, 0.5% inositol) as a skin penetration enhancer, not inositol alone. Results show no significant cytotoxicity or skin toxicity at 2.5% Putocrin®, indicating no risk for inositol in this context.